Excel Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 1.10 M
as on 09-12-2024
- Company Age 19 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -36.39%
(FY 2023)
- Profit 24.19%
(FY 2023)
- Ebitda -29.86%
(FY 2023)
- Net Worth 6.57%
(FY 2023)
- Total Assets 1.54%
(FY 2023)
About Excel Life Sciences
The Corporate was formerly known as Excel Trials India Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arjun Aiyar, Nilanjan Sinha, and Gaurav Lal serve as directors at the Company.
- CIN/LLPIN
U24231KA2005PTC174337
- Company No.
030989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2005
- Date of AGM
07 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Excel Life Sciences Private Limited offer?
Excel Life Sciences Private Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant.
Who are the key members and board of directors at Excel Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilanjan Sinha  | Director | 15-May-2019 | Current |
| Arjun Aiyar | Director | 15-May-2019 | Current |
| Gaurav Lal | Director | 17-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Excel Life Sciences.
Excel Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.39% decrease. The company also saw a substantial improvement in profitability, with a 24.19% increase in profit. The company's net worth moved up by a moderate rise of 6.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Excel Life Sciences?
In 2023, Excel Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Foresight It Solutions And Consulting India Private LimitedActive 16 years 1 monthGaurav Lal is a mutual person
Iqvia Rds (India) Private LimitedActive 22 years 29 daysArjun Aiyar, Nilanjan Sinha and 1 more are mutual person
- Iqvia Analytics Services Private LimitedActive 21 years 18 days
Arjun Aiyar, Nilanjan Sinha and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Excel Life Sciences?
Excel Life Sciences has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excel Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excel Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
